Four Considerations for Designing a Fertility Benefit
The right fertility benefit provides the right treatment to meet each individual member’s needs while delivering value to the plan.
Read MoreLeveraging comprehensive medication reviews to manage chronic diseases
Plan sponsors can leverage pharmacists in order to improve the health of their members with chronic diseases.
Read MoreExpress Scripts Further Advances Transparency and Affordability for Consumers and Clients
Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (...
Read MoreThe Need for Comprehensive Fertility Benefits: A Patient Perspective
More and more individuals are turning to fertility treatment as a way to start a family. Employers who offer comprehensive fertility benefits provide peace of mind in helping employees reach their per...
Read MoreClinically Speaking: Gene Therapies: Million-Dollar Miracles
Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...
Read MoreUnderstanding Hemophilia
Breaking down the challenges, therapies and costs associated with hemophilia.
Read MoreHow to improve specialty drug adherence for patients with inflammatory conditions
To mitigate nonadherence for inflammatory condition treatments, plan sponsors should adopt a multifaceted approach that combines clinical protocols and value-based solutions.
Read MoreWhy is prenatal care vital to a happy and healthy pregnancy?
Pregnant individuals require routine, dedicated care to ensure positive parental and fetal outcomes.
Read MoreAntibiotic Resistance: A Threat to All Of Us
When germs no longer respond to antibiotics, the cost to our health and budgets is enormous
Read MoreUncovering behind-the-scenes challenges in bringing gene therapies to market
Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.
Read More